Sigve Andersen
Papers
1
Total Citations
3
H-Index
1
About
Sigve Andersen is a clinical researcher whose work focuses on patient-reported outcomes and treatment-related toxicities in prostate cancer care, with a particular emphasis on comparing modern curative modalities. His major contribution lies in advancing the understanding of adverse health outcomes following prostatectomy, primary radiotherapy, and salvage radiotherapy, using rigorous patient-reported outcome measures (PROMs) to capture the real-world impact of treatment. Although his most-cited paper, published in 2023, has garnered 3 citations to date, it addresses a critical gap in the literature by evaluating contemporary treatment techniques often missing from heterogeneous trial designs. Andersen’s research is notable for its patient-centered approach, prioritizing the lived experiences of individuals undergoing curative therapy for prostate cancer. His work helps clinicians and patients make more informed decisions by highlighting the trade-offs between treatment efficacy and quality of life. As an emerging voice in uro-oncology, Andersen continues to contribute valuable evidence that bridges clinical outcomes and patient perspectives, making his research particularly relevant for students and clinicians interested in survivorship and personalized cancer care.
Research Focus
Key Achievements
Top Papers
- 1